Severe IgA-mediated autoimmune hemolytic anemia triggered by SARS-CoV-2 infection

Leuk Lymphoma. 2021 Aug;62(8):2037-2039. doi: 10.1080/10428194.2021.1888378. Epub 2021 Feb 22.

Authors

Aude Mausoleo¹, Soledad Henriquez¹, Cécile Goujard^{1

2}, Anne-Marie Roque-Afonso³, Nicolas Noel^{1

4}, Olivier Lambotte^{1

4}

Affiliations

¹ Clinical Immunology Department, AP-HP.Université Paris-Saclay, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
² Inserm, CESP 10, Université Paris-Saclay, Le Kremlin Bicêtre, France.
³ Department of Virology, AP-HP.Université Paris-Saclay, Hôpital Paul Brousse, Villejuif, France.
⁴ Inserm, CEA, Centre de recherche en Immunologie des infections virales et des maladies auto-immunes ImVA, Université Paris-Saclay, Le Kremlin Bicêtre, France.

PMID: 33618609
DOI: 10.1080/10428194.2021.1888378

No abstract available

Publication types

Letter

MeSH terms

Anemia, Hemolytic, Autoimmune* / diagnosis
Anemia, Hemolytic, Autoimmune* / etiology
COVID-19*
Humans
Immunoglobulin A
SARS-CoV-2

Substances

Immunoglobulin A